Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-10-028134)

Filing Details

Accession Number:: 0001209191-10-028134
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-05-17 13:00:00
Reporting Period:: 2010-05-14

Filing Date:: 2010-05-17
Accepted Time:: 2010-05-17 13:01:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882104	Pdl Biopharma Inc.	PDLI	Biological Products, (No Disgnostic Substances) (2836)	943023969

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1270013	R Christine Larson	C/O Pdl Biopharma, Inc. 932 Southwood Boulevard Incline Village NV 89451	Vice President And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-05-14	800	$5.71	39,549	No	4	P	Direct
Common Stock	Acquisiton	2010-05-14	300	$5.71	39,849	No	4	P	Direct
Common Stock	Acquisiton	2010-05-14	3,900	$5.71	43,749	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct